Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.
Revenue (Most Recent Fiscal Year) | $15.46B |
Net Income (Most Recent Fiscal Year) | $1.03B |
PE Ratio (Current Year Earnings Estimate) | 17.33 |
PE Ratio (Trailing 12 Months) | 16.11 |
PEG Ratio (Long Term Growth Estimate) | 2.48 |
Price to Sales Ratio (Trailing 12 Months) | 2.19 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.08 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 11.72 |
Pre-Tax Margin (Trailing 12 Months) | 13.00% |
Net Margin (Trailing 12 Months) | 9.37% |
Return on Equity (Trailing 12 Months) | 20.06% |
Return on Assets (Trailing 12 Months) | 7.78% |
Current Ratio (Most Recent Fiscal Quarter) | 0.98 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.68 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.66 |
Inventory Turnover (Trailing 12 Months) | 3.70 |
Book Value per Share (Most Recent Fiscal Quarter) | $5.04 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.29 |
Earnings per Share (Most Recent Fiscal Year) | $1.14 |
Diluted Earnings per Share (Trailing 12 Months) | $0.74 |
Exchange | NYSE |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
Common Shares Outstanding | 1.92B |
Free Float | 1.89B |
Market Capitalization | $33.08B |
Average Volume (Last 20 Days) | 33.87M |
Beta (Past 60 Months) | 0.83 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 1.68% |
Percentage Held By Institutions (Latest 13F Reports) | 97.64% |
Annual Dividend (Based on Last Quarter) | $0.83 |
Dividend Yield (Based on Last Quarter) | 4.81% |